Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Biemond

Showing results (171-180 of 255) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|December 6, 2024
Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot studyAafke E Gaartman, Boukje M Beuger, Lydian A de Ligt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2017
Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady stateJ W R Sins, M Schimmel, B M Luken, et al.
Transfusion|August 2, 2022
Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approachJorn J Gerritsma, Nieke van der Bolt, Robin van Bruggen, et al.
American Journal of Physiology. Renal Physiology|January 10, 2019
Iron handling by the human kidney: glomerular filtration and tubular reabsorption both contribute to urinary iron excretionSanne E G van Raaij, Alexander J Rennings, Bart J Biemond, et al.
The Lancet. Haematology|December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisJurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
American Journal of Hematology|May 11, 2024
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort studyElisabeth Dovern, Mesire Aydin, Mette D Hazenberg, et al.
American Journal of Respiratory and Critical Care Medicine|May 26, 2022
Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress SyndromeRobert F J Kullberg, Justin de Brabander, Leonoor S Boers, et al.
Haematologica|February 26, 2026
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label studyGeoffrey Z L Kuppens, Maria Armila D Ruiz, Myrthe J Van Dijk, et al.
Blood Reviews|May 27, 2019
Sickle cell disease: Clinical presentation and management of a global health challengeM E Houwing, P J de Pagter, E J van Beers, et al.
American Journal of Hematology|September 27, 2008
Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertensionEduard J van Beers, Erfan Nur, Cornelia M Schaefer-Prokop, et al.
Pageof 26

Showing results (171-180 of 255) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|December 6, 2024
Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot studyAafke E Gaartman, Boukje M Beuger, Lydian A de Ligt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2017
Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady stateJ W R Sins, M Schimmel, B M Luken, et al.
Transfusion|August 2, 2022
Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approachJorn J Gerritsma, Nieke van der Bolt, Robin van Bruggen, et al.
American Journal of Physiology. Renal Physiology|January 10, 2019
Iron handling by the human kidney: glomerular filtration and tubular reabsorption both contribute to urinary iron excretionSanne E G van Raaij, Alexander J Rennings, Bart J Biemond, et al.
The Lancet. Haematology|December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisJurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
American Journal of Hematology|May 11, 2024
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort studyElisabeth Dovern, Mesire Aydin, Mette D Hazenberg, et al.
American Journal of Respiratory and Critical Care Medicine|May 26, 2022
Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress SyndromeRobert F J Kullberg, Justin de Brabander, Leonoor S Boers, et al.
Haematologica|February 26, 2026
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label studyGeoffrey Z L Kuppens, Maria Armila D Ruiz, Myrthe J Van Dijk, et al.
Blood Reviews|May 27, 2019
Sickle cell disease: Clinical presentation and management of a global health challengeM E Houwing, P J de Pagter, E J van Beers, et al.
American Journal of Hematology|September 27, 2008
Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertensionEduard J van Beers, Erfan Nur, Cornelia M Schaefer-Prokop, et al.
Pageof 26